Rani Therapeutics to Participate in September Investor Conferences
Rani Therapeutics Holdings, Inc. - Class A (RANI)
Company Research
Source: GlobeNewswire
SAN JOSE, Calif., Sept. 03, 2024 (GLOBE NEWSWIRE) -- Rani Therapeutics Holdings, Inc. (“Rani Therapeutics” or “Rani”) (Nasdaq: RANI), a clinical-stage biotherapeutics company focused on the oral delivery of biologics and drugs, today announced that the Company will participate in two upcoming investor conferences in September 2024. These conferences include: H.C. Wainwright 26th Annual Global Investment Conference Location: Lotte New York Palace Hotel, New York, NYDate: Tuesday, September 10, 2024 at 4:30 pm E.T.Format: Company Presentation and 1x1 Investor Meetings Presenter: Chief Executive Officer, Talat Imran 2024 Cantor Global Healthcare ConferenceLocation: InterContinental Barclay Hotel, New York, NYDate: Wednesday, September 18, 2024 at 11:30am E.T.Format: Fireside Chat and 1x1 Investor MeetingsPresenter: Chief Executive Officer, Talat Imran Interested parties can register for and access the live webcasts for these conferences by visiting the “Events” section of the Rani T
Show less
Read more
Impact Snapshot
Event Time:
RANI
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
RANI alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
RANI alerts
High impacting Rani Therapeutics Holdings, Inc. - Class A news events
Weekly update
A roundup of the hottest topics
RANI
News
- Rani Therapeutics Holdings, Inc. (NASDAQ: RANI) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $9.00 price target on the stock.MarketBeat
- Rani Therapeutics Announces New Preclinical Pharmacokinetic Data Supporting Transenteric Delivery of GLP-1 Incretin TriagonistGlobeNewswire
- Rani Therapeutics to sell 3M shares at $3.00 in registered direct offering [Seeking Alpha]Seeking Alpha
- Rani Therapeutics Holdings, Inc. Announces Pricing of $10.0 Million Registered Direct Offering and Cancellation of Certain Existing WarrantsGlobeNewswire
- Oppenheimer Predicts up to 740% Rally for These 2 ‘Strong Buy' Stocks [Yahoo! Finance]Yahoo! Finance
RANI
Earnings
- 8/6/24 - Beat
RANI
Analyst Actions
- 10/18/24 - HC Wainwright
RANI
Sec Filings
- 10/17/24 - Form SC
- 10/17/24 - Form 4
- 10/16/24 - Form 8-K
- RANI's page on the SEC website